Search
Elosulfase alfa
go.drugbank.com/drugs/DB09051ApprovedInvestigationalIt was approved by the FDA in 2014 for the treatment of Morquio syndrome. Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and is marketed under the brand Vimizim™.
Products: Vimizim 1mg/ml Concentrate for Solution for Infusion, VIMIZIM® 1MG/ML SOLUCIÓN CONCENTRADA PARA INFUSIÓNDobutamine
go.drugbank.com/drugs/DB00841ApprovedInvestigationalA beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.
Products: DOBUTEL Concentrate for Solution for Infusion 50mg/ml, INOTROP (Dobutamine HCl 25mg/ml Concentrate for Solution for Infusion)Carvedilol
go.drugbank.com/drugs/DB01136ApprovedInvestigational[L7889,L7892] It is currently used to treat heart failure, left ventricular dysfunction, and hypertension. … [A182306] Carvedilol was granted FDA approval on 14 September 1995.[L7889]
Products: Dilatrend - Tab 50mg, CARVEDILOL HEXAL 50MGTenofovir disoproxil
go.drugbank.com/drugs/DB00300ApprovedInvestigationalThis drug is prescribed in combination with other drugs for the management of HIV infection as well as for Hepatitis B therapy. Tenofovir disoproxil was initially approved in 2001 [FDA label]. … Tenofovir disoproxil fumarate (a prodrug of tenofovir), marketed by Gilead Sciences under the trade name _Viread_, belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase
Mixtures: STRIBILD 150MG/150MG/200MG/245MG FILM KAPLI TABLET, 90 ADET, STRIBILD 150MG/150MG/200MG/245MG FILM KAPLI TABLET, 30 ADETProducts: PMS-tenofovir, VIREAD 245MGDihydroergotamine
go.drugbank.com/drugs/DB00320ApprovedInvestigationalformulated at 75% of the strength of the existing intranasal product. … Dihydroergotamine is used as an abortive therapy for migraines.
Products: PMS-dihydroergotamine, Migranal Nasal Spray 4mg/mlRegorafenib
go.drugbank.com/drugs/DB08896ApprovedInvestigationalApproved use of Regorafenib was expanded to treat Hepatocellular Carcinoma in April 2017. … It is used for the treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumours, and hepatocellular carcinoma. FDA approved on September 27, 2012.
Products: Stivarga Tablet 40mg, STIVARGA 40MG FILM-COATED TABLETSNicardipine
go.drugbank.com/drugs/DB00622ApprovedInvestigationalIt has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents. [PubChem] … It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects.
Products: Cardene 20mg Capsules, Nicardiin 1mg/ml Solution for InfusionMidostaurin
go.drugbank.com/drugs/DB06595ApprovedInvestigationalIt was approved on April 28, 2017 and has shown to increase the overall survival rate in patients with AML as an adjunct therapy along with chemotherapeutic agents. … It was initially characterized as a potential broad-spectrum antineoplastic agent, with activity toward diverse solid and hematopoietic tumors [A19108].
Products: Rydapt 25mg Soft Capsules, RYDAPT SOFT CAPSULE 25MGPasireotide
go.drugbank.com/drugs/DB06663ApprovedInvestigationalIt is marketed as a diaspartate salt called Signifor, which is used in the treatment of Cushing's disease.
Products: SIGNIFOR LAR POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION 20MG, Signifor LAR 20mg powder and solvent for suspension for injectionGolimumab
go.drugbank.com/drugs/DB06674ApprovedInvestigationaltreatment in patients with active psoriatic arthritis (PsA), (iii) as a single agent in patients with active ankylosing spondylitis (AS), and (iv) as a single agent in patients with moderate to severe … Thus golimumab is indicated for use in adults (i) as an adjunct to methotrexate treatment in patients with moderate to severe active rheumatoid arthritis (RA), (ii) alone or as an adjunct to methotrexate
Products: SIMPONI 50MG ILO I E FER, SIMPONI SOLUTION FOR INJECTION IN PRE-FILLED PEN 45MG/0.45ML